• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

SV Health Investors

HPS/PayMedix to Expand $25M for Healthcare Financing Solution

by Fred Pennic 01/26/2023 Leave a Comment

HPS/PayMedix to Expand $25M for Healthcare Financing Solution

What You Should Know: - Today, Health Payment Systems, Inc. (HPS)/PayMedix announced it has raised another $25M of funding to accelerate the growth of its PayMedix healthcare financing solution led by SVB Capital with partipcation from existing investors SV Health Investors, Hexagon, Inc. and Caltius Equity. - PayMedix increases health equity for all consumers by guaranteeing full and prompt payments of all in-network allowed charges for
Read More

American Well Acquires Aligned Telehealth to Create The Largest Telepsychiatry Platform

by Jasmine Pennic 11/07/2019 Leave a Comment

American Well Acquires Aligned Telehealth to Create The Largest Telepsychiatry Platform

Key Highlights- American Well has signed a definitive agreement to acquire Aligned Telehealth, a leader in the provision of behavioral telehealth and telepsychiatry services to hospitals and health plans. - The acquisition combines Aligned Telehealth’s ability to access a network of clinical experts with American Well’s digital care delivery platform. - The combination will create the largest enterprise telepsychiatry platform in the U.S.National telehealth leader American Well announced today
Read More

SV Life Sciences Rebrands As SV Health Investors, Closes $400M Fund

by Fred Pennic 04/12/2017 Leave a Comment

SV Health Investors

Boston-based healthcare and life sciences venture capital and growth equity firm SV Life Sciences has changed its name to SV Health Investors and has closed its sixth flagship fund target of $400 million. SV Health Investors' venture partner program focuses on leveraging experienced healthcare entrepreneur to serve as hands-on advisors and directors for portfolio companies. This approach contributes to SV's appeal to both potential investors and entrepreneurs. The new multi-sector focus fund
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |